Using micro-ultrasound to deliver targeted radiotherapy to patients with prostate cancer
Lawson researcher receives Terry Fox Research Institute New Investigator Award
LHSC: Verspeeten Family Cancer Centre
Improving palliative cancer treatment with existing diagnostic scans: Study reveals promising results
A recent study from London Health Sciences Centre and Lawson Health Research Institute suggests that using existing diagnostic CT scans in planning simple palliative radiation treatments can significantly cut down the waiting time for urgent treatment, resulting in a better experience for cancer...
New study using nuclear medicine and rare isotopes in the fight against cancer
In a national multicentre study, scientists at Lawson Health Research Institute and Western University are working to create rare isotopes that will be used as an important tool to help treat cancer.
Precise, high-dose radiation safe and effective for inoperable kidney cancer, study suggests
A new study published in The Lancet Oncology suggests that a very precise, high-dose form of radiotherapy called stereotactic ablative radiotherapy (SABR) may be a new treatment option for patients with inoperable kidney cancer.
Fewer high-dose radiation treatments safe and well tolerated by women with uterine cancer - study shows
LONDON,ON - Five high-dose radiation treatments targeting uterine cancer rather than the current standard 25 treatments are safe and well-tolerated by patients, a new study published in JAMA Oncology has found. SPARTACUS (Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus) — a...
Research Assistant - London Regional Cancer Program
The recruit will develop cancer imaging research databases supporting the development of artificial intelligence tools and clinical trials in oncology. The position will entail: Reading and interpreting patient charts, radiology reports, and pathology reports Retrieval of imaging and radiation...
Study looks at advanced imaging to optimize treatments for prostate cancer patients
Prostate cancer is the most common cancer among Canadian men, and it is estimated that one in eight men will be diagnosed with prostate cancer within their lifetime. Researchers at both Lawson Health Research Institute and Sunnybrook Research Institute, are teaming up on a study which is pairing...
Study may help explain why breast cancer often spreads to the lungs
A team from Lawson Health Research Institute has shown that triple-negative breast cancer cells can facilitate changes to the lung that both attract cancerous cells and allow them to grow, leading to lung metastasis. Metastasis is the spread of cancer cells from a primary tumour to different organs...
Dr. David Palma recognized with Canadian Cancer Society Award for Excellence
Dr. David Palma, Associate Scientist at Lawson Health Research Institute and Radiation Oncologist at London Health Sciences Centre (LHSC), is receiving a Canadian Cancer Society Award for Excellence. Dr. Palma was announced today as a co-recipient of the William Rawls Prize. Dr. Palma is recognized...
Influenza vaccine effective for patients with cancer
A recent study used data compiled by ICES between 2010 and 2016 from across Ontario to evaluate seasonal influenza vaccine effectiveness among patients diagnosed with cancer. Overall, the study found vaccine effectiveness to be 21 per cent against laboratory-confirmed influenza across all cancer...